Total Payments
$4,129
2024 Payments
$154.99
Companies
31
Transactions
175
Medicare Patients
2,550
Medicare Billing
$351,320
Payment Breakdown by Category
Food & Beverage$3,899 (94.4%)
Education$229.96 (5.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,899 | 171 | 94.4% |
| Education | $229.96 | 4 | 5.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $804.35 | 29 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $724.50 | 26 | $0 (2024) |
| Boston Scientific Corporation | $458.07 | 11 | $0 (2023) |
| Astellas Pharma US Inc | $253.73 | 6 | $0 (2020) |
| Amgen Inc. | $241.72 | 13 | $0 (2023) |
| Merck Sharp & Dohme LLC | $230.32 | 12 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $171.27 | 10 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $138.47 | 8 | $0 (2023) |
| PFIZER INC. | $123.11 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $115.69 | 8 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $154.99 | 2 | Abbott Laboratories ($129.50) |
| 2023 | $369.20 | 17 | Merck Sharp & Dohme LLC ($98.29) |
| 2022 | $503.17 | 21 | PFIZER INC. ($123.11) |
| 2021 | $360.42 | 22 | Novartis Pharmaceuticals Corporation ($68.79) |
| 2020 | $258.53 | 14 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($83.32) |
| 2019 | $401.11 | 16 | Boston Scientific Corporation ($152.62) |
| 2018 | $984.42 | 45 | Astellas Pharma US Inc ($222.09) |
| 2017 | $1,097 | 38 | Abbott Laboratories ($430.29) |
All Payment Transactions
175 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $25.49 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/10/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $129.50 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/15/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Cardiology | ||||||
| 11/30/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.64 | General |
| Category: Cardiovascular | ||||||
| 10/25/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Cardiology | ||||||
| 10/09/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $32.32 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/29/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.06 | General |
| Category: Cardiovascular | ||||||
| 09/11/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $28.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/01/2023 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 08/23/2023 | BIOTRONIK INC. | Edora 8 DR-T (Device) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/25/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.70 | General |
| Category: Cardiovascular | ||||||
| 04/11/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $29.36 | General |
| Category: Not Applicable | ||||||
| 04/04/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/20/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/23/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/16/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.69 | General |
| Category: Cardiovascular | ||||||
| 01/27/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/12/2023 | Boston Scientific Corporation | LATITUDE Communicator Power Supply (Device) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: LATITUDE_CRM | ||||||
| 01/03/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Cardiology | ||||||
| 11/09/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/02/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $31.44 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/01/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/17/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/22/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/18/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 308 | 417 | $135,038 | $34,570 |
| 2022 | 13 | 558 | 809 | $272,529 | $70,201 |
| 2021 | 17 | 745 | 1,778 | $535,119 | $143,447 |
| 2020 | 17 | 939 | 1,671 | $410,659 | $103,102 |
Total Patients
2,550
Total Services
4,675
Medicare Billing
$351,320
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 34 | 67 | $19,688 | $5,992 | 30.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 50 | $23,969 | $5,903 | 24.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 34 | $19,107 | $4,379 | 22.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 17 | 17 | $17,283 | $3,868 | 22.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 55 | $10,262 | $3,424 | 33.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 34 | $11,197 | $2,829 | 25.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 15 | 15 | $10,101 | $2,173 | 21.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 19 | $6,693 | $1,942 | 29.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $6,590 | $1,679 | 25.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 29 | 29 | $6,207 | $1,517 | 24.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 63 | 85 | $3,940 | $863.96 | 21.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 82 | 221 | $66,088 | $17,792 | 26.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 89 | 99 | $57,222 | $15,506 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 128 | $48,896 | $12,302 | 25.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 42 | $22,554 | $5,499 | 24.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 35 | 36 | $21,924 | $5,281 | 24.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 22 | 22 | $14,388 | $3,293 | 22.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 54 | 56 | $11,648 | $3,034 | 26.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 26 | 26 | $9,550 | $2,425 | 25.4% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2022 | 11 | 11 | $7,876 | $2,028 | 25.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 72 | 104 | $4,472 | $1,112 | 24.9% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2022 | 19 | 19 | $4,370 | $1,030 | 23.6% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2022 | 11 | 11 | $1,738 | $445.99 | 25.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2022 | 23 | 23 | $989.00 | $243.96 | 24.7% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2022 | 11 | 11 | $814.00 | $208.41 | 25.6% |
About Dr. Prem Pillay, MD
Dr. Prem Pillay, MD is a Nuclear Cardiology healthcare provider based in Chandler, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669438552.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Prem Pillay, MD has received a total of $4,129 in payments from pharmaceutical and medical device companies, with $154.99 received in 2024. These payments were reported across 175 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,899).
As a Medicare-enrolled provider, Pillay has provided services to 2,550 Medicare beneficiaries, totaling 4,675 services with total Medicare billing of $351,320. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Nuclear Cardiology
- Other Specialties Cardiovascular Disease, Cardiovascular Disease
- Location Chandler, AZ
- Active Since 04/21/2006
- Last Updated 12/11/2025
- Taxonomy Code 207UN0901X
- Entity Type Individual
- NPI Number 1669438552
Products in Payments
- LifeVest (Device) $724.50
- VERQUVO (Drug) $230.32
- VIGILANT (Device) $195.25
- Corlanor (Drug) $183.41
- ELIQUIS (Drug) $178.05
- XARELTO (Drug) $171.27
- EnSite Velocity System Mapping Disposables (Device) $139.63
- Assurity Pacemaker (Device) $131.38
- GALLANT (Device) $129.50
- EMBLEM S-ICD (Device) $120.73
- Connectivity and Remote care (Device) $116.00
- ENTRESTO (Drug) $115.69
- FARXIGA (Drug) $84.96
- Merlin Connectivity and Remote (Device) $81.33
- Vascepa (Drug) $77.70
- ZONTIVITY (Drug) $65.08
- BYSTOLIC (Drug) $64.65
- ICDs (Device) $62.10
- CAMZYOS (Drug) $60.40
- Repatha (Biological) $58.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.